Type I interferons as regulators of human antigen presenting cell functions

Toxins

Volumn 6, Issue 6, 2014, Pages 1696-1723

  Gessani, Sandra ^a   Conti, Lucia ^a   Del Cornò, Manuela ^a   Belardelli, Filippo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antigen uptake processing presentation; Cell differentiation activation; Dendritic cell; microRNA; T cell response; Transcriptional profile; Type I interferon

Indexed keywords

ALPHA DEFENSIN; CD123 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MICRORNA; STAT1 PROTEIN; TOLL LIKE RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; INTRACELLULAR SIGNALING; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; ADAPTIVE IMMUNITY; ANIMAL; ANTIGEN PRESENTING CELL; BIOLOGICAL MODEL; BLOOD; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MODELS, IMMUNOLOGICAL;

EID: 84901930342     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins6061696     Document Type: Review

References (130)

1. Ivashkiv, L.B.; Donlin, L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014, 14, 36-49.
2. De Weerd, N.A.; Nguyen, T. The interferons and their receptors-Distribution and regulation. Immunol. Cell Biol. 2012, 90, 483-491.
3. Hertzog, P.J.; Williams, B.R. Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 2013, 24, 217-225.
4. Vilcek, J. Fifty years of interferon research: Aiming at a moving target. Immunity 2006, 25, 343-348.
5. Gresser, I. The antitumor effects of interferon: A personal history. Biochimie 2007, 89, 723-728.
6. Wang, B.X.; Rahbar, R.; Fish, E.N. Interferon: Current status and future prospects in cancer therapy. J. Interferon Cytokine Res. 2011, 31, 545-552.
7. Belardelli, F.; Gresser, I. The neglected role of type I interferon in the t-cell response: Implications for its clinical use. Immunol. Today 1996, 17, 369-372.
8. Tough, D.F. Modulation of t-cell function by type I interferon. Immunol. Cell Biol. 2012, 90, 492-497.
9. Hervas-Stubbs, S.; Perez-Gracia, J.L.; Rouzaut, A.; Sanmamed, M.F.; Le Bon, A.; Melero, I. Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 2011, 17, 2619-2627.
10. Le Bon, A.; Thompson, C.; Kamphuis, E.; Durand, V.; Rossmann, C.; Kalinke, U.; Tough, D.F. Cutting edge: Enhancement of antibody responses through direct stimulation of b and T cells by type I IFN. J. Immunol. 2006, 176, 2074-2078.
11. Stackaruk, M.L.; Lee, A.J.; Ashkar, A.A. Type I interferon regulation of natural killer cell function in primary and secondary infections. Expert Rev. Vaccines 2013, 12, 875-884.
12. Belardelli, F.; Ferrantini, M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 2002, 23, 201-208.
13. Bracci, L.; La Sorsa, V.; Belardelli, F.; Proietti, E. Type I interferons as vaccine adjuvants against infectious diseases and cancer. Expert Rev. Vaccines 2008, 7, 373-381.
14. Merad, M.; Sathe, P.; Helft, J.; Miller, J.; Mortha, A. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 2013, 31, 563-604.
15. Steinman, R.M.; Cohn, Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973, 137, 1142-1162.
16. Shortman, K.; Naik, S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7, 19-30.
17. Schlitzer, A.; Ginhoux, F. Organization of the mouse and human dc network. Curr. Opin. Immunol. 2014, 26, 90-99.
18. Vieira, P.L.; de Jong, E.C.; Wierenga, E.A.; Kapsenberg, M.L.; Kalinski, P. Development of th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 2000, 164, 4507-4512.
19. Zou, G.M.; Tam, Y.K. Cytokines in the generation and maturation of dendritic cells: Recent advances. Eur. Cytokine Netw. 2002, 13, 186-199.
20. Conti, L.; Gessani, S. Gm-csf in the generation of dendritic cells from human blood monocyte precursors: Recent advances. Immunobiology 2008, 213, 859-870.
21. Santini, S.M.; Lapenta, C.; Logozzi, M.; Parlato, S.; Spada, M.; di Pucchio, T.; Belardelli, F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in hu-pbl-scid mice. J. Exp. Med. 2000, 191, 1777-1788.
22. Paquette, R.L.; Hsu, N.C.; Kiertscher, S.M.; Park, A.N.; Tran, L.; Roth, M.D.; Glaspy, J.A. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukoc. Biol. 1998, 64, 358-367.
23. Radvanyi, L.G.; Banerjee, A.; Weir, M.; Messner, H. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. 1999, 50, 499-509.
24. Luft, T.; Pang, K.C.; Thomas, E.; Hertzog, P.; Hart, D.N.; Trapani, J.; Cebon, J. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 1998, 161, 1947-1953.
25. Della Bella, S.; Nicola, S.; Riva, A.; Biasin, M.; Clerici, M.; Villa, M.L. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha. J. Leukoc. Biol. 2004, 75, 106-116.
26. Korthals, M.; Safaian, N.; Kronenwett, R.; Maihofer, D.; Schott, M.; Papewalis, C.; Diaz Blanco, E.; Winter, M.; Czibere, A.; Haas, R.; et al. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J. Transl. Med. 2007, 5, 46.
27. Mohty, M.; Vialle-Castellano, A.; Nunes, J.A.; Isnardon, D.; Olive, D.; Gaugler, B. Ifn-alpha skews monocyte differentiation into toll-like receptor 7-expressing dendritic cells with potent functional activities. J. Immunol. 2003, 171, 3385-3393.
28. Carbonneil, C.; Aouba, A.; Burgard, M.; Cardinaud, S.; Rouzioux, C.; Langlade-Demoyen, P.; Weiss, L. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells. Aids 2003, 17, 1731-1740.
29. Renneson, J.; Salio, M.; Mazouz, N.; Goldman, M.; Marchant, A.; Cerundolo, V. Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells. Clin. Exp. Immunol. 2005, 139, 468-475.
30. Huang, Y.M.; Hussien, Y.; Yarilin, D.; Xiao, B.G.; Liu, Y.J.; Link, H. Interferon-beta induces the development of type 2 dendritic cells. Cytokine 2001, 13, 264-271.
31. Mazouz, N.; Detournay, O.; Buelens, C.; Renneson, J.; Trakatelli, M.; Lambermont, M.; Goldman, M.; Toungouz, M. Immunostimulatory properties of human dendritic cells generated using IFN-beta associated either with IL-3 or gm-csf. Cancer Immunol. Immunother. 2005, 54, 1010-1017.
32. Garcin, G.; Bordat, Y.; Chuchana, P.; Monneron, D.; Law, H.K.; Piehler, J.; Uze, G. Differential activity of type I interferon subtypes for dendritic cell differentiation. PLoS ONE 2013, 8, e58465.
33. Buelens, C.; Bartholome, E.J.; Amraoui, Z.; Boutriaux, M.; Salmon, I.; Thielemans, K.; Willems, F.; Goldman, M. Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper t-cell stimulatory properties. Blood 2002, 99, 993-998.
34. Papewalis, C.; Jacobs, B.; Wuttke, M.; Ullrich, E.; Baehring, T.; Fenk, R.; Willenberg, H.S.; Schinner, S.; Cohnen, M.; Seissler, J.; et al. Ifn-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J. Immunol. 2008, 180, 1462-1470.
35. Bracci, L.; Schumacher, R.; Provenzano, M.; Adamina, M.; Rosenthal, R.; Groeper, C.; Zajac, P.; Iezzi, G.; Proietti, E.; Belardelli, F.; et al. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require toll-like receptor triggering. J. Immunother. 2008, 31, 466-474.
36. Farkas, A.; Tonel, G.; Nestle, F.O. Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells. Br. J. Dermatol. 2008, 158, 921-929.
37. Parlato, S.; Santini, S.M.; Lapenta, C.; di Pucchio, T.; Logozzi, M.; Spada, M.; Giammarioli, A.M.; Malorni, W.; Fais, S.; Belardelli, F. Expression of ccr-7, mip-3beta, and th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: Importance for the rapid acquisition of potent migratory and functional activities. Blood 2001, 98, 3022-3029.
38. Gauzzi, M.C.; Purificato, C.; Donato, K.; Jin, Y.; Wang, L.; Daniel, K.C.; Maghazachi, A.A.; Belardelli, F.; Adorini, L.; Gessani, S. Suppressive effect of 1alpha,25-dihydroxyvitamin d3 on type I IFN-mediated monocyte differentiation into dendritic cells: Impairment of functional activities and chemotaxis. J. Immunol. 2005, 174, 270-276.
39. Rouzaut, A.; Garasa, S.; Teijeira, A.; Gonzalez, I.; Martinez-Forero, I.; Suarez, N.; Larrea, E.; Alfaro, C.; Palazon, A.; Dubrot, J.; et al. Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-alpha. Eur. J. Immunol. 2010, 40, 3054-3063.
40. Parlato, S.; Romagnoli, G.; Spadaro, F.; Canini, I.; Sirabella, P.; Borghi, P.; Ramoni, C.; Filesi, I.; Biocca, S.; Gabriele, L.; et al. Lox-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells. Blood 2010, 115, 1554-1563.
41. Cardone, M.; Ikeda, K.N.; Varano, B.; Belardelli, F.; Millefiorini, E.; Gessani, S.; Conti, L. Opposite regulatory effects of IFN-beta and IL-3 on c-type lectin receptors, antigen uptake, and phagocytosis in human macrophages. J. Leukoc. Biol. 2014, 95, 161-168.
42. Lapenta, C.; Santini, S.M.; Spada, M.; Donati, S.; Urbani, F.; Accapezzato, D.; Franceschini, D.; Andreotti, M.; Barnaba, V.; Belardelli, F. Ifn-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Eur. J. Immunol. 2006, 36, 2046-2060.
43. Lattanzi, L.; Rozera, C.; Marescotti, D.; D'Agostino, G.; Santodonato, L.; Cellini, S.; Belardelli, F.; Gavioli, R.; Ferrantini, M. Ifn-alpha boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity. Immunobiology 2011, 216, 537-547.
44. Tosello, V.; Zamarchi, R.; Merlo, A.; Gorza, M.; Piovan, E.; Mandruzzato, S.; Bronte, V.; Wang, X.; Ferrone, S.; Amadori, A.; et al. Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived dc differentiated in the presence of IFN-alpha or IL-4. Eur. J. Immunol. 2009, 39, 56-66.
45. Carbonneil, C.; Saidi, H.; Donkova-Petrini, V.; Weiss, L. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: Modulation by autocrine IL-10, enhanced t-cell apoptosis and T regulatory type 1 cells. Int. Immunol. 2004, 16, 1037-1052.
46. Lapenta, C.; Santini, S.M.; Logozzi, M.; Spada, M.; Andreotti, M.; di Pucchio, T.; Parlato, S.; Belardelli, F. Potent immune response against hiv-1 and protection from virus challenge in hu-pbl-scid mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha. J. Exp. Med. 2003, 198, 361-367.
47. Santodonato, L.; D'Agostino, G.; Nisini, R.; Mariotti, S.; Monque, D.M.; Spada, M.; Lattanzi, L.; Perrone, M.P.; Andreotti, M.; Belardelli, F.; et al. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent epstein-barr virus-specific CD8+ T cell response. J. Immunol. 2003, 170, 5195-5202.
48. Padovan, E.; Spagnoli, G.C.; Ferrantini, M.; Heberer, M. Ifn-alpha2a induces ip-10/cxcl10 and mig/cxcl9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J. Leukoc. Biol. 2002, 71, 669-676.
49. Cabanas, C.; Hogg, N. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1. Proc. Natl. Acad. Sci. USA 1993, 90, 5838-5842.
50. Gauzzi, M.C.; Canini, I.; Eid, P.; Belardelli, F.; Gessani, S. Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J. Immunol. 2002, 169, 3038-3045.
51. Lehner, M.; Felzmann, T.; Clodi, K.; Holter, W. Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 2001, 98, 736-742.
52. McRae, B.L.; Nagai, T.; Semnani, R.T.; van Seventer, J.M.; van Seventer, G.A. Interferon-alpha and-beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood 2000, 96, 210-217.
53. Bartholome, E.J.; Willems, F.; Crusiaux, A.; Thielemans, K.; Schandene, L.; Goldman, M. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: Selective inhibition of CD40-dependent interleukin-12 secretion. J. Interferon Cytokine Res. 1999, 19, 471-478.
54. Hussien, Y.; Sanna, A.; Soderstrom, M.; Link, H.; Huang, Y.M. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. J. Neuroimmunol. 2001, 121, 102-110.
55. Dauer, M.; Pohl, K.; Obermaier, B.; Meskendahl, T.; Robe, J.; Schnurr, M.; Endres, S.; Eigler, A. Interferon-alpha disables dendritic cell precursors: Dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and t-cell stimulation. Immunology 2003, 110, 38-47.
56. Ito, T.; Amakawa, R.; Inaba, M.; Ikehara, S.; Inaba, K.; Fukuhara, S. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 2001, 166, 2961-2969.
57. Luft, T.; Luetjens, P.; Hochrein, H.; Toy, T.; Masterman, K.A.; Rizkalla, M.; Maliszewski, C.; Shortman, K.; Cebon, J.; Maraskovsky, E. Ifn-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int. Immunol. 2002, 14, 367-380.
58. Trepiakas, R.; Pedersen, A.E.; Met, O.; Svane, I.M. Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function. Vaccine 2009, 27, 2213-2219.
59. Svane, I.M.; Nikolajsen, K.; Walter, M.R.; Buus, S.; Gad, M.; Claesson, M.H.; Pedersen, A.E. Characterization of monocyte-derived dendritic cells maturated with IFN-alpha. Scand. J. Immunol. 2006, 63, 217-222.
60. Nguyen-Pham, T.N.; Lim, M.S.; Nguyen, T.A.; Lee, Y.K.; Jin, C.J.; Lee, H.J.; Hong, C.Y.; Ahn, J.S.; Yang, D.H.; Kim, Y.K.; et al. Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists. Cell. Mol. Immunol. 2011, 8, 341-347.
61. Simmons, D.P.; Wearsch, P.A.; Canaday, D.H.; Meyerson, H.J.; Liu, Y.C.; Wang, Y.; Boom, W.H.; Harding, C.V. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class ii mhc synthesis and antigen processing. J. Immunol. 2012, 188, 3116-3126.
62. Longman, R.S.; Braun, D.; Pellegrini, S.; Rice, C.M.; Darnell, R.B.; Albert, M.L. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood 2007, 109, 1113-1122.
63. Nagai, T.; Devergne, O.; Mueller, T.F.; Perkins, D.L.; van Seventer, J.M.; van Seventer, G.A. Timing of IFN-beta exposure during human dendritic cell maturation and naive th cell stimulation has contrasting effects on th1 subset generation: A role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive th cell differentiation. J. Immunol. 2003, 171, 5233-5243.
64. Wiesemann, E.; Sonmez, D.; Heidenreich, F.; Windhagen, A. Interferon-beta increases the stimulatory capacity of monocyte-derived dendritic cells to induce IL-13, IL-5 and IL-10 in autologous t-cells. J. Neuroimmunol. 2002, 123, 160-169.
65. Jensen, P.E. Recent advances in antigen processing and presentation. Nat. Immunol. 2007, 8, 1041-1048.
66. Wang, J.; Nikrad, M.P.; Travanty, E.A.; Zhou, B.; Phang, T.; Gao, B.; Alford, T.; Ito, Y.; Nahreini, P.; Hartshorn, K.; et al. Innate immune response of human alveolar macrophages during influenza a infection. PLoS One 2012, 7, e29879.
67. Song, Q.; Meng, Y.; Wang, Y.; Li, M.; Zhang, J.; Xin, S.; Wang, L.; Shan, F. Maturation inside and outside bone marrow dendritic cells (bmdcs) modulated by interferon-alpha (IFN-alpha). Int. Immunopharmacol. 2013, 17, 843-849.
68. Le Bon, A.; Etchart, N.; Rossmann, C.; Ashton, M.; Hou, S.; Gewert, D.; Borrow, P.; Tough, D.F. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003, 4, 1009-1015.
69. Schiavoni, G.; Mattei, F.; Gabriele, L. Type I interferons as stimulators of dc-mediated cross-priming: Impact on anti-tumor response. Front. Immunol. 2013, 4, 483.
70. Kuchtey, J.; Chefalo, P.J.; Gray, R.C.; Ramachandra, L.; Harding, C.V. Enhancement of dendritic cell antigen cross-presentation by cpg DNA involves type I IFN and stabilization of class I mhc mrna. J. Immunol. 2005, 175, 2244-2251.
71. Gray, R.C.; Kuchtey, J.; Harding, C.V. Cpg-b odns potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent mhc-i cross-presentation in dcs as effectively as cpg-a and cpg-c odns. J. Leukoc. Biol. 2007, 81, 1075-1085.
72. Hoebe, K.; Beutler, B. Lps, dsrna and the interferon bridge to adaptive immune responses: Trif, tram, and other tir adaptor proteins. J. Endotoxin Res. 2004, 10, 130-136.
73. Zietara, N.; Lyszkiewicz, M.; Gekara, N.; Puchalka, J.; Dos Santos, V.A.; Hunt, C.R.; Pandita, T.K.; Lienenklaus, S.; Weiss, S. Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70. J. Immunol. 2009, 183, 1099-1109.
74. Lorenzi, S.; Mattei, F.; Sistigu, A.; Bracci, L.; Spadaro, F.; Sanchez, M.; Spada, M.; Belardelli, F.; Gabriele, L.; Schiavoni, G. Type I IFNs control antigen retention and survival of CD8alpha(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming. J. Immunol. 2011, 186, 5142-5150.
75. Spadaro, F.; Lapenta, C.; Donati, S.; Abalsamo, L.; Barnaba, V.; Belardelli, F.; Santini, S.M.; Ferrantini, M. IFN-alpha enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. Blood 2012, 119, 1407-1417.
76. Teijaro, J.R.; Ng, C.; Lee, A.M.; Sullivan, B.M.; Sheehan, K.C.; Welch, M.; Schreiber, R.D.; de la Torre, J.C.; Oldstone, M.B. Persistent lcmv infection is controlled by blockade of type I interferon signaling. Science 2013, 340, 207-211.
77. Wilson, E.B.; Yamada, D.H.; Elsaesser, H.; Herskovitz, J.; Deng, J.; Cheng, G.; Aronow, B.J.; Karp, C.L.; Brooks, D.G. Blockade of chronic type I interferon signaling to control persistent lcmv infection. Science 2013, 340, 202-207.
78. Yang, X.; Zhang, X.; Fu, M.L.; Weichselbaum, R.R.; Gajewski, T.F.; Guo, Y.; Fu, Y.X. Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses. Cancer Cell 2014, 25, 37-48.
79. Huber, J.P.; Farrar, J.D. Regulation of effector and memory t-cell functions by type I interferon. Immunology 2011, 132, 466-474.
80. Starbeck-Miller, G.R.; Xue, H.H.; Harty, J.T. Il-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J. Exp. Med. 2014, 211, 105-120.
81. Santini, S.M.; Lapenta, C.; Donati, S.; Spadaro, F.; Belardelli, F.; Ferrantini, M. Interferon-alpha-conditioned human monocytes combine a th1-orienting attitude with the induction of autologous th17 responses: Role of IL-23 and IL-12. PLoS One 2011, 6, e17364.
82. Trinchieri, G.; Pflanz, S.; Kastelein, R.A. The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses. Immunity 2003, 19, 641-644.
83. Matsui, M.; Moriya, O.; Belladonna, M.L.; Kamiya, S.; Lemonnier, F.A.; Yoshimoto, T.; Akatsuka, T. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis c virus-specific cytotoxic T lymphocytes in hla-a*0201 transgenic mice. J. Virol. 2004, 78, 9093-9104.
84. Ha, S.J.; Kim, D.J.; Baek, K.H.; Yun, Y.D.; Sung, Y.C. Il-23 induces stronger sustained ctl and th1 immune responses than IL-12 in hepatitis c virus envelope protein 2 DNA immunization. J. Immunol. 2004, 172, 525-531.
85. Detournay, O.; Mazouz, N.; Goldman, M.; Toungouz, M. Il-6 produced by type I IFN dc controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells. Hum. Immunol. 2005, 66, 460-468.
86. Rodriguez, A.; Vigorito, E.; Clare, S.; Warren, M.V.; Couttet, P.; Soond, D.R.; van Dongen, S.; Grocock, R.J.; Das, P.P.; Miska, E.A.; et al. Requirement of bic/microrna-155 for normal immune function. Science 2007, 316, 608-611.
87. Steiner, D.F.; Thomas, M.F.; Hu, J.K.; Yang, Z.; Babiarz, J.E.; Allen, C.D.; Matloubian, M.; Blelloch, R.; Ansel, K.M. Microrna-29 regulates t-box transcription factors and interferon-gamma production in helper T cells. Immunity 2011, 35, 169-181.
88. Thai, T.H.; Calado, D.P.; Casola, S.; Ansel, K.M.; Xiao, C.; Xue, Y.; Murphy, A.; Frendewey, D.; Valenzuela, D.; Kutok, J.L.; et al. Regulation of the germinal center response by microrna-155. Science 2007, 316, 604-608.
89. Bai, Y.; Qian, C.; Qian, L.; Ma, F.; Hou, J.; Chen, Y.; Wang, Q.; Cao, X. Integrin CD11b negatively regulates tlr9-triggered dendritic cell cross-priming by upregulating microrna-146a. J. Immunol. 2012, 188, 5293-5302.
90. Wang, P.; Gu, Y.; Zhang, Q.; Han, Y.; Hou, J.; Lin, L.; Wu, C.; Bao, Y.; Su, X.; Jiang, M.; et al. Identification of resting and type I IFN-activated human nk cell mirnomes reveals microrna-378 and microrna-30e as negative regulators of nk cell cytotoxicity. J. Immunol. 2012, 189, 211-221.
91. Ebert, M.S.; Sharp, P.A. Roles for micrornas in conferring robustness to biological processes. Cell 2012, 149, 515-524.
92. Turner, M.L.; Schnorfeil, F.M.; Brocker, T. Micrornas regulate dendritic cell differentiation and function. J. Immunol. 2011, 187, 3911-3917.
93. El Gazzar, M.; McCall, C.E. Micrornas regulatory networks in myeloid lineage development and differentiation: Regulators of the regulators. Immunol. Cell Biol. 2012, 90, 587-593.
94. Zhan, Y.; Wu, L. Functional regulation of monocyte-derived dendritic cells by micrornas. Protein Cell 2012, 3, 497-507.
95. Moller, I.; Michel, K.; Frech, N.; Burger, M.; Pfeifer, D.; Frommolt, P.; Veelken, H.; Thomas-Kaskel, A.K. Dendritic cell maturation with poly(i:C)-based versus pge2-based cytokine combinations results in differential functional characteristics relevant to clinical application. J. Immunother. 2008, 31, 506-519.
96. Messmer, D.; Messmer, B.; Chiorazzi, N. The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. Int. Immunol. 2003, 15, 491-503.
97. De Veer, M.J.; Holko, M.; Frevel, M.; Walker, E.; Der, S.; Paranjape, J.M.; Silverman, R.H.; Williams, B.R. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 2001, 69, 912-920.
98. Samarajiwa, S.A.; Forster, S.; Auchettl, K.; Hertzog, P.J. Interferome: The database of interferon regulated genes. Nucleic Acids Res. 2009, 37, D852-D857.
99. Lynn, D.J.; Chan, C.; Naseer, M.; Yau, M.; Lo, R.; Sribnaia, A.; Ring, G.; Que, J.; Wee, K.; Winsor, G.L.; et al. Curating the innate immunity interactome. BMC Syst. Biol. 2010, 4, 117.
100. Korb, M.; Rust, A.G.; Thorsson, V.; Battail, C.; Li, B.; Hwang, D.; Kennedy, K.A.; Roach, J.C.; Rosenberger, C.M.; Gilchrist, M.; et al. The innate immune database (IIDB). BMC Immunol. 2008, 9, doi:10.1186/1471-2172-9-7.
101. Stroncek, D.F.; Basil, C.; Nagorsen, D.; Deola, S.; Arico, E.; Smith, K.; Wang, E.; Marincola, F.M.; Panelli, M.C. Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms. J. Transl. Med. 2005, 3, doi:10.1186/1479-5876-3-24.
102. Schlaak, J.F.; Hilkens, C.M.; Costa-Pereira, A.P.; Strobl, B.; Aberger, F.; Frischauf, A.M.; Kerr, I.M. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J. Biol. Chem. 2002, 277, 49428-49437.
103. Barnes, E.; Salio, M.; Cerundolo, V.; Medlin, J.; Murphy, S.; Dusheiko, G.; Klenerman, P. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob. Agents Chemother. 2004, 48, 3382-3389.
104. Izaguirre, A.; Barnes, B.J.; Amrute, S.; Yeow, W.S.; Megjugorac, N.; Dai, J.; Feng, D.; Chung, E.; Pitha, P.M.; Fitzgerald-Bocarsly, P. Comparative analysis of irf and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 2003, 74, 1125-1138.
105. Takauji, R.; Iho, S.; Takatsuka, H.; Yamamoto, S.; Takahashi, T.; Kitagawa, H.; Iwasaki, H.; Iida, R.; Yokochi, T.; Matsuki, T. Cpg-DNA-induced IFN-alpha production involves p38 mapk-dependent stat1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 2002, 72, 1011-1019.
106. Forster, S. Interferon signatures in immune disorders and disease. Immunol. Cell Biol. 2012, 90, 520-527.
107. Arico, E.; Belardelli, F. Interferon-alpha as antiviral and antitumor vaccine adjuvants: Mechanisms of action and response signature. J. Interferon Cytokine Res. 2012, 32, 235-247.
108. Arico, E.; Castiello, L.; Urbani, F.; Rizza, P.; Panelli, M.C.; Wang, E.; Marincola, F.M.; Belardelli, F. Concomitant detection of ifnalpha signature and activated monocyte/dendritic cell precursors in the peripheral blood of ifnalpha-treated subjects at early times after repeated local cytokine treatments. J. Transl. Med. 2011, 9, doi:10.1186/1479-5876-9-67.
109. Rubins, K.H.; Hensley, L.E.; Jahrling, P.B.; Whitney, A.R.; Geisbert, T.W.; Huggins, J.W.; Owen, A.; Leduc, J.W.; Brown, P.O.; Relman, D.A. The host response to smallpox: Analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc. Natl. Acad. Sci. USA 2004, 101, 15190-15195.
110. David, M. Interferons and micrornas. J. Interferon Cytokine Res. 2010, 30, 825-828.
111. Parlato, S.; Bruni, R.; Fragapane, P.; Salerno, D.; Marcantonio, C.; Borghi, P.; Tataseo, P.; Ciccaglione, A.R.; Presutti, C.; Romagnoli, G.; et al. Ifn-alpha regulates blimp-1 expression via mir-23a and mir-125b in both monocytes-derived dc and pdc. PLoS ONE 2013, 8, e72833.
112. Tili, E.; Croce, C.M.; Michaille, J.J. Mir-155: On the crosstalk between inflammation and cancer. Int. Rev. Immunol. 2009, 28, 264-284.
113. Chen, T.; Li, Z.; Jing, T.; Zhu, W.; Ge, J.; Zheng, X.; Pan, X.; Yan, H.; Zhu, J. Microrna-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40l in oxldl-stimulated dendritic cells. FEBS Lett. 2011, 585, 567-573.
114. Zhou, H.; Huang, X.; Cui, H.; Luo, X.; Tang, Y.; Chen, S.; Wu, L.; Shen, N. Mir-155 and its star-form partner mir-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116, 5885-5894.
115. Karrich, J.J.; Jachimowski, L.C.; Libouban, M.; Iyer, A.; Brandwijk, K.; Taanman-Kueter, E.W.; Nagasawa, M.; de Jong, E.C.; Uittenbogaart, C.H.; Blom, B. Microrna-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood 2013, 122, 3001-3009.
116. Cobos Jimenez, V.; Booiman, T.; de Taeye, S.W.; van Dort, K.A.; Rits, M.A.; Hamann, J.; Kootstra, N.A. Differential expression of hiv-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons. Sci. Rep. 2012, 2, doi: 10.1038/srep00763.
117. Thornburg, N.J.; Hayward, S.L.; Crowe, J.E., Jr. Respiratory syncytial virus regulates human micrornas by using mechanisms involving beta interferon and nf-kappab. mBio 2012, 3, doi:10.1128/mBio.00220-12.
118. Tang, Y.; Luo, X.; Cui, H.; Ni, X.; Yuan, M.; Guo, Y.; Huang, X.; Zhou, H.; de Vries, N.; Tak, P.P.; et al. Microrna-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60, 1065-1075.
119. Hecker, M.; Goertsches, R.H.; Fatum, C.; Koczan, D.; Thiesen, H.J.; Guthke, R.; Zettl, U.K. Network analysis of transcriptional regulation in response to intramuscular interferon-beta-1a multiple sclerosis treatment. Pharmacogenomics J. 2012, 12, 134-146.
120. Scagnolari, C.; Zingariello, P.; Vecchiet, J.; Selvaggi, C.; Racciatti, D.; Taliani, G.; Riva, E.; Pizzigallo, E.; Antonelli, G. Differential expression of interferon-induced micrornas in patients with chronic hepatitis c virus infection treated with pegylated interferon alpha. Virol. J. 2010, 7, doi: 10.1186/1743-422X-7-311.
121. Pedersen, I.M.; Cheng, G.; Wieland, S.; Volinia, S.; Croce, C.M.; Chisari, F.V.; David, M. Interferon modulation of cellular micrornas as an antiviral mechanism. Nature 2007, 449, 919-922.
122. Nathans, R.; Chu, C.Y.; Serquina, A.K.; Lu, C.C.; Cao, H.; Rana, T.M. Cellular microrna and p bodies modulate host-hiv-1 interactions. Mol. Cell 2009, 34, 696-709.
123. Wiesen, J.L.; Tomasi, T.B. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 2009, 46, 1222-1228.
124. Ahmed, S.; Maratha, A.; Butt, A.Q.; Shevlin, E.; Miggin, S.M. Trif-mediated TLR3 and TLR4 signaling is negatively regulated by adam15. J. Immunol. 2013, 190, 2217-2228.
125. Fang, T.C.; Schaefer, U.; Mecklenbrauker, I.; Stienen, A.; Dewell, S.; Chen, M.S.; Rioja, I.; Parravicini, V.; Prinjha, R.K.; Chandwani, R.; et al. Histone h3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J. Exp. Med. 2012, 209, 661-669.
126. Lin, L.; Hou, J.; Ma, F.; Wang, P.; Liu, X.; Li, N.; Wang, J.; Wang, Q.; Cao, X. Type I IFN inhibits innate IL-10 production in macrophages through histone deacetylase 11 by downregulating microrna-145. J. Immunol. 2013, 191, 3896-3904.
127. Rizza, P.; Capone, I.; Moretti, F.; Proietti, E.; Belardelli, F. Ifn-alpha as a vaccine adjuvant: Recent insights into the mechanisms and perspectives for its clinical use. Expert Rev. Vaccines 2011, 10, 487-498.
128. Diamond, M.S.; Kinder, M.; Matsushita, H.; Mashayekhi, M.; Dunn, G.P.; Archambault, J.M.; Lee, H.; Arthur, C.D.; White, J.M.; Kalinke, U.; et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 2011, 208, 1989-2003.
129. Fuertes, M.B.; Woo, S.R.; Burnett, B.; Fu, Y.X.; Gajewski, T.F. Type I interferon response and innate immune sensing of cancer. Trends Immunol. 2013, 34, 67-73.
130. Santini, S.M.; di Pucchio, T.; Lapenta, C.; Parlato, S.; Logozzi, M.; Belardelli, F. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 2002, 22, 1071-1080.